Total Funding
67
54
Total FundingSeries C raised
Growth Score
-2 pts
Heat Score
2 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
66437
Brexogen is a biotechnology cell therapy research and development company.
About the Company
Brexogen is a clinical-stage biotechnology company developing exosome-based regenerative medicines for autoimmune, dermatology, and metabolic diseases. The company’s proprietary BG-Platform uses stem cell–derived exosomes to create cell-free therapeutic treatments, with lead programs targeting atopic dermatitis, myocardial infarction, and tissue
regeneration.
